PT-141
$55.00
PT-141 (Bremelanotide) is a pharmaceutical-grade peptide that enhances sexual desire, increases libido, and improves erectile function through central melanocortin receptor activation, making it ideal for advanced sexual dysfunction, arousal, and libido research protocols.
Out of stock
Buy PT-141 Peptide for Sale
Product Specifications
| Category | Details |
|---|---|
| Peptide Name | PT-141 (Bremelanotide) |
| Purity | 99%+ pharmaceutical grade |
| Available Vial Size | 10mg vials |
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1025.2 g/mol |
| Administration | Subcutaneous injection (research use only) |
| Storage | Store refrigerated at 2-8°C |
What is PT-141?
PT-141 (Bremelanotide) is a synthetic peptide derived from the melanocortin pathway, studied primarily for its powerful effects on sexual function and arousal in both men and women. Unlike PDE5 inhibitors that focus on vascular function, PT-141 works through the central nervous system, directly enhancing sexual desire, libido, and arousal response. In research models, PT-141 is also studied for its potential applications in treating sexual dysfunction, hypoactive sexual desire disorders, and improving sexual satisfaction across a broad range of subjects.
How Does PT-141 Work?
PT-141 activates melanocortin receptors (primarily MC3R and MC4R) in the brain’s hypothalamus, triggering neural pathways responsible for sexual arousal:
-
Increases libido and sexual desire in both men and women
-
Enhances erectile function independent of nitric oxide pathways
-
Improves sexual response without directly affecting vascular performance
-
Influences central arousal centers through neurochemical stimulation
-
Supports research models in sexual dysfunction and hypoactive libido studies
Unlike traditional ED drugs, PT-141 directly stimulates desire rather than simply improving physical function.
PT-141 Benefits
-
Enhances sexual desire and libido in both sexes
-
Improves erectile function in male research models
-
May assist female arousal and sexual satisfaction studies
-
Acts centrally through melanocortin receptors (non-vascular mechanism)
-
Supports research into hypoactive sexual desire disorder (HSDD)
-
Fast-acting with extended duration of effect
-
Minimal systemic side effects when properly dosed
PT-141 Dosage (Research Purposes Only)
-
Standard Dosage: 1mg to 2mg per dose
-
Frequency: As needed, not exceeding 3 times per week in most protocols
-
Administration: Subcutaneous injection 30 to 60 minutes before desired effect
-
Cycle Length: Used as needed depending on research model
Dosing may be adjusted depending on subject response and protocol design in research applications.
Potential Side Effects
PT-141 is generally well tolerated in controlled research studies. Potential dose-dependent side effects may include:
-
Temporary facial flushing or warmth
-
Mild nausea, especially at higher doses
-
Transient headaches or lightheadedness
-
Rare increase in blood pressure (dose-dependent)
Side effects typically resolve within a few hours and diminish with repeated use and proper titration.
Why Researchers Buy PT-141 from AnabolicPharm
AnabolicPharm supplies pharmaceutical-grade PT-141, fully lab-tested for purity, stability, and peptide integrity. Researchers rely on AnabolicPharm for clinical-quality sexual function peptides used in advanced libido enhancement research, erectile dysfunction studies, HSDD models, and neuroendocrine arousal research protocols.
Every vial is produced under strict GMP standards, securely packaged, accurately labeled, and shipped globally with full transparency and fast delivery for professional peptide research.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.

Reviews
There are no reviews yet.